The Latest Emcure Pharmaceuticals IPO GMP was ₹371, updated on July 6th, 2024, at 08:00 AM. With a price band of ₹1008.00, the estimated listing price for the Emcure Pharma IPO is ₹1379 (cap price + today’s GMP), resulting in an expected percentage gain/loss per share of 36.81%.
Retail Subject to Sauda: ₹3900
Small HNI Subject to Sauda: ₹58500
The Emcure Pharmaceuticals IPO is set to open on July 3. This Mainline IPO aims to raise ₹1952.03 crores. The price band for the Emcure Pharmaceuticals IPO is set at ₹960 to ₹1008, with a market lot of 14 shares. Explore the latest updates on Emcure Pharmaceuticals IPO GMP, including Grey Market Premium (GMP), Kostak rates, and Subject to Sauda rates.
Emcure Pharmaceuticals, an Indian company, focuses on developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company is driven by research and development (R&D), offering a diverse product portfolio that includes orals, injectables, and biotherapeutics. This has enabled Emcure to reach a wide range of target markets in over 70 countries, with a strong presence in India, Europe, and Canada.
We update the GMP daily, and based on the grey market activities of the last 10 sessions, today’s IPO GMP indicates an upward trend, suggesting a strong listing. The GMP has ranged from ₹0 to ₹371. Stay with us for daily updates on the Emcure Pharma IPO GMP and the expected listing price.
**The GMP prices shown here are only news related to the grey market. We do not trade/deal in grey market or subject to rates (sub2), nor do we recommend trading in grey market.
Emcure Pharmaceuticals IPO GMP Day-wise
| GMP Date | IPO Price | GMP | Sub2 Sauda Rate | Estimated Listing Price |
| 06-07-2024 | 1008 | ₹371 | 3900/58500 | ₹1379 (36.81%) |
| 05-07-2024 | 1008 | ₹371 | 3900/58500 | ₹1379 (36.81%) |
| 04-07-2024 | 1008 | ₹335 | 3600/54000 | ₹1343 (33.23%) |
| 03-07-2024 | 1008 | ₹330 | 3500/52500 | ₹1338 (32.74%) |
| 02-07-2024 | 1008 | ₹299 | 3200/48000 | ₹1307 (29.66%) |
| 01-07-2024 | 1008 | ₹285 | 3000/45000 | ₹1293 (28.27%) |
| 30-06-2024 | 1008 | ₹264 | 2800/42000 | ₹1272 (26.19%) |
| 29-06-2024 | 1008 | ₹264 | 2800/42000 | ₹1272 (26.19%) |
| 28-06-2024 | 1008 | ₹271 | 2900/43500 | ₹1279 (26.88%) |
| 27-06-2024 | ₹0 | — | ₹ (0%) |
IPO Grey Market Premium (GMP)
The grey market premium (GMP) is the price at which an IPO is traded in the unofficial, unregulated grey market prior to its official listing. The GMP provides an indication of how the IPO might perform on its listing day. A positive GMP suggests that the IPO is expected to yield a profit, while a negative GMP indicates it may list at a discount.
However, it is important to remember that IPO GMP is highly volatile. Making an investment decision based solely on the GMP is risky. Therefore, consider all factors carefully before deciding whether to invest in the Emcure Pharma IPO.
Emcure Pharmaceuticals IPO GMP Dates
Stay informed with the latest updates on the Emcure Pharma IPO. Dates will be updated as soon as they are announced.
| IPO Activity | Date |
| IPO Open Date | 03-07-2024 |
| IPO Close Date | 05-07-2024 |
| Basis of Allotment Finalisation Date* | 08-07-2024 |
| Refunds Initiation* | 09-07-2024 |
| Credit of Shares to Demat Account* | 09-07-2024 |
| IPO Listing Date* | 10-07-2024 |
DISCLAIMER: The financial information published here should not be construed as an offer to buy or sell securities or as financial advice. It is provided for educational and informational purposes only and should not be relied upon for investment decisions. Readers should consult a qualified financial advisor before making any investment decisions based on this information. Any investment decisions made based on this information are solely at the reader’s own risk. Investors should be aware that equity market investments are subject to unpredictable market risks. The author does not intend to invest in this offering.
